Methylprednisolone/tozinameran/plasmaImmune-mediated thrombotic thrombocytopenic purpura and no response: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1900卷 / 1期

关键词：

D O I：

10.1007/s40278-022-12564-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：212 / 212

相关论文

共 50 条

[21] Refractory thrombotic thrombocytopenic purpura - a case report
Twayana, A. R.
Szeto, C.
Tabowei, G.
Bajaj, K.
Gurru, P.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2024, 367 : S193 - S194
[22] TozinameranImmune thrombotic thrombocytopenic purpura: case report
Reactions Weekly, 2022, 1921 (1) : 272 - 272
[23] PembrolizumabImmune thrombotic thrombocytopenic purpura: case report
Reactions Weekly, 2021, 1858 (1) : 329 - 329
[24] TozinameranImmune thrombotic thrombocytopenic purpura: case report
Reactions Weekly, 2022, 1916 (1) : 397 - 397
[25] GolimumabFirst report of thrombotic thrombocytopenic purpura: case report
Reactions Weekly, 2018, 1708 (1) : 162 - 162
[26] HydroxychloroquineFirst report of thrombotic thrombocytopenic purpura: case report
Reactions Weekly, 2011, 1352 (1) : 21 - 21
[27] MetronidazoleFirst report of thrombotic thrombocytopenic purpura: case report
Reactions Weekly, 2007, 1161 (1) : 18 - 18
[28] UstekinumabFirst report of thrombotic thrombocytopenic purpura: case report
Reactions Weekly, 2012, 1425 (1) : 36 - 36
[29] MefloquineFirst report of thrombotic thrombocytopenic purpura: case report
Reactions Weekly, 2006, 1088 (1) : 16 - 16
[30] TozinameranAcquired thrombotic thrombocytopenic purpura: case report
Reactions Weekly, 2022, 1900 (1) : 308 - 308

← 1 2 3 4 5 →